🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/05/2018 9,38 9,75 9,16 9,60 +1,91% 6,29% 1.285.400
14/05/2018 9,98 10,10 8,87 9,42 -4,66% 12,32% 3.072.800
11/05/2018 9,15 9,89 8,92 9,88 +8,33% 10,60% 2.691.000
10/05/2018 8,98 9,49 8,83 9,12 +1,33% 7,35% 2.812.300
09/05/2018 8,42 9,60 8,11 9,00 +16,13% 17,70% 5.661.400
08/05/2018 7,77 7,82 7,58 7,75 -0,26% 3,09% 757.500
07/05/2018 7,17 7,78 7,17 7,77 +8,37% 8,51% 1.116.200
04/05/2018 7,36 7,40 7,09 7,17 -2,85% 4,21% 999.000
03/05/2018 7,13 7,46 7,01 7,38 +3,36% 6,37% 1.539.800
02/05/2018 6,41 7,23 6,31 7,14 +11,04% 14,35% 2.109.700
01/05/2018 6,45 6,49 6,31 6,43 +0,16% 2,81% 992.300
30/04/2018 6,74 6,77 6,41 6,42 -3,60% 5,33% 656.400
27/04/2018 6,77 6,86 6,55 6,66 -1,19% 4,58% 553.200
26/04/2018 6,60 6,76 6,55 6,74 +1,97% 3,18% 516.600
25/04/2018 6,51 6,70 6,33 6,61 +1,38% 5,68% 616.600
24/04/2018 6,89 6,89 6,47 6,52 -4,82% 6,10% 1.012.400
23/04/2018 7,00 7,04 6,74 6,85 -1,72% 4,36% 939.900
20/04/2018 6,91 7,03 6,87 6,97 +0,29% 2,24% 672.700
19/04/2018 6,98 7,09 6,85 6,95 -0,86% 3,42% 659.600
18/04/2018 6,88 7,07 6,75 7,01 +2,34% 4,69% 715.600
17/04/2018 6,85 6,97 6,77 6,85 +0,15% 2,92% 860.700
16/04/2018 7,23 7,23 6,82 6,84 -5,26% 5,74% 895.600
13/04/2018 7,27 7,27 6,99 7,22 -0,41% 3,89% 746.500
12/04/2018 7,30 7,42 7,08 7,25 +0,28% 4,59% 983.800
11/04/2018 7,01 7,30 6,86 7,23 +6,95% 6,28% 1.524.300
10/04/2018 6,49 6,80 6,43 6,76 +5,96% 5,70% 1.341.700
09/04/2018 6,43 6,61 6,37 6,38 +0,16% 3,73% 1.272.100
06/04/2018 6,77 6,93 6,26 6,37 -7,01% 9,91% 1.487.800
05/04/2018 7,17 7,17 6,80 6,85 -3,66% 5,16% 1.186.900
04/04/2018 6,60 7,14 6,31 7,11 +6,28% 12,48% 1.389.800